In those unique times when patients are eager to take care of their health and cooperate with the pharma, it is important not to miss out on the moment and speak to the audience, using the language that is the most native to them. Not only in terms of translation but using the exact channel and exact message they are eager to get.
To become a trusted companion and help patients in their quest to become healthier, pharma is forced to create an enormous number of materials without any guarantee to be heard. Despite being translated into many languages; it may be 100% valuable but may not use the sufficient knowledge of patients to engage them in active treatment.
Modular content, which being buzzy lately, creates a unified content development standard inside the organization and releases a lot of positive energy to explore the needs of the audience.
Being among pioneers of modular content, today Viseven demonstrates a clear benefit of this approach in TOP-50 pharma enterprises: from better content discovery, reuse, streamlined MLR to the ability to personalize. On March 8th (17:15 — 17:45 CET), exclusively at Next Normal, we are ready to share our experience during the session “Contentverse for patient experience: how modular content can become a gamechanger.”
- Nataliya Andreychuk, CEO, Viseven
- Souhila Ahdjoudj, Senior Director Worldwide Field Medical Excellence, Bristol Myers Squibb
- Megan Hughes (Reutin), Global Head of Data Science & Strategy, Grunenthal
Register now to fuel some emotional debates as spring in pharma begins at #NEXTNormal.